BridgeMD
Compares treatment options for Antiphospholipid Syndrome
Official title Comparison of Clopidogrel-based Antiplatelet Therapy Versus Warfarin As Secondary Prevention Strategy for AntiPhospholipid Syndrome-related STROKE
ClinicalTrials.gov ID: NCT05995600
What this study is testing
What is Antiplatelet Drug?
Antiplatelet Drug is an investigational medicine, given as a treatment applied to the skin, being studied as a potential treatment for antiphospholipid syndrome.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- Antiphospholipid syndrome (APS) has a close association with ischemic stroke; however, the optimal treatment strategy for APS-related stroke has yet to be established. The clinical guidelines suggest using warfarin for APS-related stroke, but these suggestions are largely based on retrospective studies from the 1990s and expert opinion, rather than high-quality clinical trials.
- Phase 4: studies an already-approved treatment
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 19 and older
You may be able to join if
- Age 19 years or older
- History of ischemic stroke (cerebral infarction, transient ischemic attack, or retinal arterial ischemic event)
- Patients who meet the laboratory diagnostic criteria for antiphospholipid syndrome (APS)
- Patients or guardians who agree to the study protocol and sign with informed consent
You likely can't join if
- Patients with high-risk antiphospholipid antibody profile (triple positivity; persistent high-titers exceeding 80 U/mL of anti-cardiolipin or anti-β2...
- Systemic lupus erythematous
- Patients unable to discontinue previously taken anticoagulants or antiplatelet agents (e.g., atrial fibrillation, valvular heart disease, or a...
- Women who are pregnant, breastfeeding, or intending to become pregnant during the study period
- Deemed unsuitable for participation in the study for more than four years, as per the investigators' discretion
The study team makes the final eligibility decision.
Where it's taking place
- Anyang, South Korea
- Busan, South Korea
- Cheongju-si, South Korea
- Chuncheon, South Korea
- Daegu, South Korea
- Daejeon, South Korea
- Guri-si, South Korea
- Gwangju, South Korea
- Incheon, South Korea
- Jeju City, South Korea
- Jeonju, South Korea
- Sejong, South Korea
- Seongnam, South Korea
- Seoul, South Korea
- Uijeongbu-si, South Korea
- Yongin, South Korea
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 19 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Anyang, South Korea; Busan, South Korea; Cheongju-si, South Korea; Chuncheon, South Korea; Daegu, South Korea; Daejeon, South Korea and 10 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.